{"id":4986,"date":"2023-08-07T13:41:50","date_gmt":"2023-08-07T11:41:50","guid":{"rendered":"https:\/\/www.ptc.cz\/sto-lijecimo\/lymfomy\/protonova-lecba-lymfomu\/"},"modified":"2024-06-21T14:36:55","modified_gmt":"2024-06-21T12:36:55","slug":"protonska-terapija-malignih-limfoma","status":"publish","type":"page","link":"https:\/\/www.ptc.cz\/hr\/sto-lijecimo\/limfomi\/protonska-terapija-malignih-limfoma\/","title":{"rendered":"Protonska terapija malignih limfoma"},"content":{"rendered":"<div class=\"gdc_row\">\n<div class=\"gdc_column gdc_chalf\">\n<div class=\"gdc_inner\">\n<p><strong>Na\u0161e postupy protonov\u00e9 radioterapie p\u0159i l\u00e9\u010db\u011b malign\u00edho lymfomu v&nbsp;oblasti mediastina (mezihrud\u00ed) byly za\u0159azeny do sv\u011btov\u00fdch l\u00e9\u010debn\u00fdch protokol\u016f, jsou p\u0159eb\u00edr\u00e1ny ostatn\u00edmi sv\u011btov\u00fdmi protonov\u00fdmi centry a&nbsp;u<\/strong>mo\u017e\u0148uj\u00ed naprosto z\u00e1sadn\u00edm zp\u016fsobem <strong>sn\u00ed\u017eit oz\u00e1\u0159en\u00ed nap\u0159. srdce a&nbsp;plic, a&nbsp;t\u00edm v\u00fdznamn\u011b eliminovat riziko vzniku srde\u010dn\u00edch a&nbsp;plicn\u00edch onemocn\u011bn\u00ed<\/strong> (jako jsou nap\u0159. srde\u010dn\u00ed infarkt, poruchy srde\u010dn\u00edho rytmu, plicn\u00ed fibr\u00f3za aj.). Protonov\u00e1 l\u00e9\u010dba tak\u00e9 dok\u00e1\u017ee v\u00fdrazn\u011b eliminovat oz\u00e1\u0159en\u00ed m\u00edchy, a&nbsp;d\u00edky tomu sn\u00ed\u017eit riziko jej\u00edho po\u0161kozen\u00ed.<\/p>\n<p><strong>Malign\u00ed lymfomy jsou onemocn\u011bn\u00ed, kter\u00e9 velmi \u010dasto postihuje osoby v&nbsp;mlad\u00e9m v\u011bku. Pacienti se po onkologick\u00e9 l\u00e9\u010db\u011b ve vysok\u00e9m procentu uzdrav\u00ed, proto je \u017e\u00e1douc\u00ed v&nbsp;maxim\u00e1ln\u00ed mo\u017en\u00e9 m\u00ed\u0159e p\u0159edch\u00e1zet jak\u00fdmkoli vedlej\u0161\u00edm \u00fa\u010dink\u016fm l\u00e9\u010dby. P<\/strong><strong>at\u0159\u00ed k&nbsp;n\u00e1dor\u016fm vysoce citliv\u00fdm k&nbsp;l\u00e9\u010db\u011b z\u00e1\u0159en\u00edm. L\u00e9\u010dba z\u00e1\u0159en\u00edm je v\u011bt\u0161inou doporu\u010dena jako l\u00e9\u010dba dopl\u0148kov\u00e1 po p\u0159edchoz\u00ed syst\u00e9mov\u00e9 l\u00e9\u010db\u011b (chemoterapii, biologick\u00e9 l\u00e9\u010db\u011b). Problematika oza\u0159ov\u00e1n\u00ed malign\u00edch lymfom\u016f spo\u010d\u00edv\u00e1 v&nbsp;redukci d\u00e1vky na&nbsp;okoln\u00ed rizikov\u00e9 org\u00e1ny, kter\u00e9 nen\u00ed \u00a0ve v\u011bt\u0161in\u011b p\u0159\u00edpad\u016f p\u0159i b\u011b\u017en\u00e9 radioterapii spolehliv\u011b dos\u00e1hnout.\u00a0 Z&nbsp;dlouhodob\u00e9ho hlediska pacienty po l\u00e9\u010db\u011b z\u00e1\u0159en\u00edm ohro\u017euje zejm\u00e9na v\u00fdvoj sekund\u00e1rn\u00edch malignit a&nbsp;kardiovaskul\u00e1rn\u00edch onemocn\u011bn\u00ed.<\/strong><\/p>\n<\/div>\n<\/div>\n<div class=\"gdc_column gdc_chalf\">\n<div class=\"gdc_inner\">\n<p><strong>Z\u00e1sadn\u00ed je v\u017edy pe\u010dliv\u00e9 zv\u00e1\u017een\u00ed indikace oz\u00e1\u0159en\u00ed. <\/strong>Nutnost za\u0159azen\u00ed radioterapie do l\u00e9\u010debn\u00e9ho sch\u00e9matu je potvrzov\u00e1na klinick\u00fdmi studiemi. V&nbsp;\u010cR vych\u00e1z\u00edme z&nbsp;doporu\u010den\u00ed Kooperativn\u00ed lymfomov\u00e9 skupiny (KLS), kter\u00e1 reflektuj\u00ed nejnov\u011bj\u0161\u00ed v\u00fdsledky t\u011bchto klinick\u00fdch studi\u00ed a&nbsp;jsou pravideln\u011b aktualizov\u00e1na. <strong>P\u0159i\u00a0vlastn\u00edm proveden\u00ed radioterapie vych\u00e1z\u00edme tak\u00e9 z\u00a0doporu\u010den\u00ed ILROG<\/strong> (International Lymphoma Radiation Oncology Group). Bylo potvrzeno 14 studiemi, \u017ee protonov\u00e1 radioterapie signifikantn\u011b sni\u017euje radia\u010dn\u00ed z\u00e1t\u011b\u017e rizikov\u00fdch org\u00e1n\u016f a&nbsp;m\u011bla\u00a0 by b\u00fdt proto zva\u017eov\u00e1na u&nbsp;pacient\u016f, u&nbsp;nich\u017e je schopn\u00e1 v\u00fdznamn\u011b sn\u00ed\u017eit d\u00e1vky na&nbsp;rizikov\u00e9 struktury.<\/p>\n<p><iframe loading=\"lazy\" title=\"Protonov\u00e1 l\u00e9\u010dba malign\u00edch lymfom\u016f\" width=\"500\" height=\"281\" src=\"https:\/\/www.youtube.com\/embed\/_camxJG2RZA?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe><\/p>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":4826,"parent":4983,"menu_order":363,"comment_status":"closed","ping_status":"closed","template":"template-service-detail-with-anchor-sidebar.php","meta":{"footnotes":""},"class_list":["post-4986","page","type-page","status-publish","has-post-thumbnail","hentry"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.ptc.cz\/hr\/wp-json\/wp\/v2\/pages\/4986","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ptc.cz\/hr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.ptc.cz\/hr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.ptc.cz\/hr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ptc.cz\/hr\/wp-json\/wp\/v2\/comments?post=4986"}],"version-history":[{"count":1,"href":"https:\/\/www.ptc.cz\/hr\/wp-json\/wp\/v2\/pages\/4986\/revisions"}],"predecessor-version":[{"id":5001,"href":"https:\/\/www.ptc.cz\/hr\/wp-json\/wp\/v2\/pages\/4986\/revisions\/5001"}],"up":[{"embeddable":true,"href":"https:\/\/www.ptc.cz\/hr\/wp-json\/wp\/v2\/pages\/4983"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.ptc.cz\/hr\/wp-json\/wp\/v2\/media\/4826"}],"wp:attachment":[{"href":"https:\/\/www.ptc.cz\/hr\/wp-json\/wp\/v2\/media?parent=4986"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}